Does acute pain associated with herpes zoster respond to treatment with gabapentin?
Moulin
Dwight
D
Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada. dwight.moulin@lhsc.on.ca
D000208:Acute Disease; D000588:Amines / Q000008:administration & dosage / Q000627:therapeutic use*; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use*; D018592:Cross-Over Studies; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000077206:Gabapentin; D006562:Herpes Zoster / Q000150:complications*; D006801:Humans; D009437:Neuralgia / Q000209:etiology / Q000517:prevention & control; D010146:Pain / Q000188:drug therapy* / Q000209:etiology*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000627:therapeutic use*
D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin